ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, off-the-shelf c ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

The Innovax vPTMF certified by the CVMP is based on a turkey herpesvirus vector backbone ... embryonated chicken eggs against relevant viral diseases. To submit marketing authorisation applications ...

Transgene, ProBioGen join forces to advance individualized cancer vaccine development: Strasbourg, France Thursday, November 7, 2024, 11:00 Hrs [IST] Transgene, a biotech company ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

With dengue fever spreading to colder climates, Island Pharmaceuticals is working on a preventative and therapeutic solution.

On the other hand, people are deprived of clean drinking water and there are periodic spikes in vaccine-preventable and ...